Name: 10% Potassium Chloride Solution Compounding by Noor Chemist
SKU: 10290
Availability: InStock

10% Potassium Chloride Solution Compounding by Noor Chemist

₨ 450

Potassium chloride 10% in normal saline
Sterile concentrate for IV dilution only
Severe hypokalemia treatment
AJK-licensed electrolyte solution

Description

This sterile-compounded solution licensed by the Government of AJ&K provides high-concentration potassium chloride (KCl) 10% (1.34 mmol/mL) in 0.9% sodium chloride base. Reserved for severe hypokalemia (<2.5 mmol/L) under cardiac monitoring, it enables rapid electrolyte correction while maintaining osmolarity (2000 mOsm/L). Not for direct IV push – fatal if administered undiluted.

Composition & Specifications

Component	Concentration	Pharmacological Role
Potassium Chloride	10% w/v	1000 mg/mL (13.4 mEq/mL)
Sodium Chloride	0.9% w/v	Isotonic vehicle (308 mOsm/L)
Water for Injection	q.s.	USP-grade sterile solvent
*pH: 5.0-7.0	Osmolarity: 2000 mOsm/L*

Primary Clinical Indications

Critical Hypokalemia: Serum K⁺ <2.5 mmol/L with ECG changes (U-waves, ST depression)
TPN Supplementation: As additive to parenteral nutrition
Diuretic-Induced Losses: Refractory to oral replacement
Metabolic Alkalosis: With concomitant chloride deficiency

Critical Administration Protocol

Parameter	Requirement
Dilution	Must dilute to ≤40 mEq/L in IV fluid
Infusion Rate	Max 10 mEq/hour (20 mEq/hour in ICU with cardiac monitoring)
IV Line	Central line preferred; peripheral only if ≤40 mEq/L
ECG Monitoring	Continuous during infusion
Max Daily Dose	200 mEq (15mL of this concentrate)

Life-Threatening Risks

☠️ FATAL IF:

Administered undiluted (cardiac arrest within minutes)
Infused >40 mEq/hour without monitoring (ventricular fibrillation)
Given via IV push (even 1-2mL can be lethal)
Used in renal impairment (CrCl <20 mL/min)

Precautions

⚠️ Absolute Contraindications:

Hyperkalemia (>5.0 mmol/L)
Acute renal failure
Addison’s disease
Concurrent potassium-sparing diuretics

⚠️ Adverse Effects:

Phlebitis (peripheral administration)
Hyperkalemia (overcorrection)
Tissue necrosis (extravasation)

Disclaimer

All compounded preparations by Noor Chemist are freshly prepared upon receipt of your prescription or order to ensure maximum potency and therapeutic efficacy. Due to the meticulous quality control processes required for extemporaneous compounding, some formulations may experience a 1-day preparation delay to achieve optimal stability and performance. Product images depicting packaging and labeling are for illustrative reference only; actual containers, labels, and auxiliary materials may vary based on batch-specific pharmaceutical standards.

These formulations are designed for short-term use (typically 30-90 days), as extemporaneous compounds lack industrial preservatives. For specific storage instructions and shelf-life details pertaining to your formulation, please contact our pharmacists via our Contact Us portal.

Important Safety Notice: Skin sensitivity to active or inert ingredients may occur even with physician-recommended formulations. We strongly advise performing a patch test before full application: Apply a pea-sized amount to clean inner forearm skin, wait 24 hours, and discontinue use if redness, itching, or swelling develops. Individual reactions to ingredients like salicylic acid, essential oils, or penetration enhancers may vary. Consult your healthcare provider if you have known sensitivities.